Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 배나영 | - |
dc.contributor.author | 안태권 | - |
dc.contributor.author | 오명숙 | - |
dc.contributor.author | 고현석 | - |
dc.contributor.author | Hyungun Oh | - |
dc.contributor.author | Gunhyuk Park | - |
dc.contributor.author | 양현옥 | - |
dc.date.accessioned | 2015-12-03T00:41:04Z | - |
dc.date.available | 2015-12-03T00:41:04Z | - |
dc.date.issued | 201103 | - |
dc.identifier.citation | VOL 134, NO 2, 313-322 | - |
dc.identifier.issn | 0378-8741 | - |
dc.identifier.other | 35849 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/40575 | - |
dc.description.abstract | Aim of study: Modified Yeoldahanso-tang (MYH) is a Korean herbal formula, containing 10 herbs: Pueraria lobata (Willd.) Ohwi, Angelica tenuissima Nakai, Scutellaria baicalensis Georgi, Platycodon grandiflorum (Jacq), Angelicae Dahurica, Cimicifuga heracleifolia Kom, Raphanus sativa L., Polygala tenuifolia (Willd.), Acorus gramineus Soland. and Dimocarpus longan Lour. The constitutive ratio of the ten herbs is at 6:4:2:1:2:2:2:4:6:6 in dry weight. MYH has been used to treat amnesia, hypochondria and dementia in Korea. In this study, we explored the possibility of using MYH in the prevention and treatment of Parkinson's disease (PD). Specifically, we made an effort to demonstrate the neuroprotective effects of MYH using experimental methods similar to those used in a recent study of PD. Materials and methods: 1-Methyl-4-phenylpyridinium (MPP+) (400 μM) was used to induce cytotoxicity in NGF (nerve growth factor)-differentiated PC12 cells. Cell viability was measured using a MTT assay. Induction of autophagy by MYH in NGF-differentiated PC12 cells was measured using an immunoblotting assay with LC3 and beclin 1 antibodies. The proteasomal inhibitor lactacystin (10 μM) was used to cause UPS dysfunction in NGF-differentiated PC12 cells. Clearance of aggregated proteins by MYH was measured using an immunoblotting assay with an ubiquitin antibody. 1-Methyl-4-phenyl-1,2,3,6-tetrahydrophenylpyridine (MPTP) (20 mg/kg, 4 times i.p.) caused substantia nigra injuries in C57BL/6 mice. Dopamine (DA) neurons were identified using a tyrosine hydroxylase-immunohistochemistry (TH-IHC) assay with a rabbit anti-TH antibody. Results: Our findings indicate that MYH provides protection against MPP+-induced injury in NGF-differentiated PC12 cell. And MYH provides neuroprotection against lactacystin-induced NGF-differentiated PC12 cell death, which effect is partially mediated by autophagy enhancement through enhanced degradation of a | - |
dc.publisher | Journal of ethnopharmacology | - |
dc.subject | Modified Youldahanso-tang (MYH) | - |
dc.subject | Neuroprotection | - |
dc.subject | Autophagy | - |
dc.subject | Parkinson’s disease | - |
dc.subject | 1-Methyl-4-phenyl-1,2,3,6- | - |
dc.subject | tetrahydrophenylpyridine | - |
dc.subject | MPTP | - |
dc.subject | Lactacystin | - |
dc.title | The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease | - |
dc.type | Article | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.